Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
Lancet (London, England)（2023）
摘要
Erasmus University Medical Center and Biotronik.
更多查看译文
关键词
acute coronary syndrome,coronary disease,complete revascularisation,biovasc,open-label,non-inferiority
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要